Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Telix Pharmaceuticals Lim...

    NASDAQ: TLX · Real-Time Price · USD
    17.66
    0.18 (1.03%)
    At close: Jun 05, 2025, 3:59 PM
    17.36
    -1.70%
    After-hours: Jun 05, 2025, 04:04 PM EDT

    Telix Pharmaceuticals Statistics

    Share Statistics

    Telix Pharmaceuticals has - shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 n/a

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,241

    FTD / Avg. Volume

    n/a
    		 4.49%

    Short Selling Information

    The latest short interest is 10.88K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 10.88K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Telix Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.78, with a Debt / Equity ratio of 1.02.

    Current Ratio

    n/a
    		 2.78

    Quick Ratio

    n/a
    		 2.66

    Debt / Equity

    n/a
    		 1.02

    Debt / EBITDA

    n/a
    		 6.28

    Debt / FCF

    n/a
    		 64.63

    Interest Coverage

    n/a
    		 2.25

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 n/a

    Employee Count

    n/a
    		 undefined

    Asset Turnover

    n/a
    		 0.52

    Inventory Turnover

    n/a
    		 7.17

    Taxes

    Income Tax

    n/a
    		 6.14M

    Effective Tax Rate

    n/a
    		 10.95%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 2.41, so Telix Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.41

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 16.89

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 54.16

    Average Volume (20 Days)

    n/a
    		 27,614

    Income Statement

    In the last 12 months, Telix Pharmaceuticals had revenue of 783.21M and earned 49.92M in profits. Earnings per share was 0.

    Revenue

    n/a
    		 783.21M

    Gross Profit

    n/a
    		 509.68M

    Operating Income

    n/a
    		 82.13M

    Net Income

    n/a
    		 49.92M

    EBITDA

    n/a
    		 92.55M

    EBIT

    n/a
    		 92.55M

    Earnings Per Share (EPS)

    n/a
    		 0
    Full Income Statement

    Balance Sheet

    The company has 710.35M in cash and 581.45M in debt, giving a net cash position of 128.9M.

    Cash & Cash Equivalents

    n/a
    		 710.35M

    Total Debt

    n/a
    		 581.45M

    Net Cash

    n/a
    		 128.9M

    Retained Earnings

    n/a
    		 -212.96M

    Total Assets

    n/a
    		 1.52B

    Working Capital

    n/a
    		 587.65M
    Full Balance Sheet

    Cash Flow

    Operating Cash Flow

    n/a
    		 n/a

    Capital Expenditures

    n/a
    		 -34.03M

    Free Cash Flow

    n/a
    		 9M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross margin is 65.08%, with operating and profit margins of 10.49% and 6.37%.

    Gross Margin

    n/a
    		 65.08%

    Operating Margin

    n/a
    		 10.49%

    Pretax Margin

    n/a
    		 7.16%

    Profit Margin

    n/a
    		 6.37%

    EBITDA Margin

    n/a
    		 11.82%

    EBIT Margin

    n/a
    		 10.49%

    FCF Margin

    n/a
    		 1.15%

    Dividends & Yields

    TLX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TLX is $22, which is 24.6% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $22

    Price Target Difference

    n/a
    		 24.6%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 3.8

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist